The Pharmacogenomics Market is projected to reach $19.5 billion by 2031, at a CAGR of 8.9% during the forecast period 2024–2031. The pharmacogenomics market includes consumables, instruments, and software & services. The pharmacogenomics market is driven by the growing therapeutic